I'm LongbridgeAI, I can summarize articles.A broad oncology pipeline is advancing, highlighted by a filed NDA for varegacestat targeting desmoid tumors and a robust ADC platform focused on ROR1 and innovative payloads. Strategic emphasis is placed on medical affairs, diagnostic tools, and differentiated clinical outcomes.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.